600572 康恩贝
已收盘 10-15 15:00:00
资讯
新帖
简况
10月14日康恩贝发布公告,股东减持1000万股
证券之星 · 10-14 19:01
10月14日康恩贝发布公告,股东减持1000万股
康恩贝(600572.SH):康恩贝集团拟减持不超1%股份
智通财经 · 10-14 17:56
康恩贝(600572.SH):康恩贝集团拟减持不超1%股份
康恩贝:进入“十五五”阶段,公司在外延并购方面将聚焦做长长板
证券之星 · 10-09
康恩贝:进入“十五五”阶段,公司在外延并购方面将聚焦做长长板
康恩贝:公司当前暂无发行超短期融资券、中期票据安排
证券之星 · 10-09
康恩贝:公司当前暂无发行超短期融资券、中期票据安排
康恩贝:截至9月30日,公司股东总户数为90,869户
证券之星 · 10-09
康恩贝:截至9月30日,公司股东总户数为90,869户
康恩贝(600572)披露2026年第三季度股票期权激励计划自主行权结果暨股份变动公告,10月8日股价下跌0.23%
证券之星 · 10-08
康恩贝(600572)披露2026年第三季度股票期权激励计划自主行权结果暨股份变动公告,10月8日股价下跌0.23%
康恩贝(600572.SH)子公司盐酸达泊西汀片获得药品注册证书
智通财经 · 10-08
康恩贝(600572.SH)子公司盐酸达泊西汀片获得药品注册证书
股市必读:康恩贝新发布《公司第十一届董事会第二十一次(临时)会议决议公告》
证券之星 · 10-08
股市必读:康恩贝新发布《公司第十一届董事会第二十一次(临时)会议决议公告》
康恩贝(600572)9月28日主力资金净买入1260.59万元
证券之星 · 09-29
康恩贝(600572)9月28日主力资金净买入1260.59万元
康恩贝新提交“Conba7Spro”、“康恩贝倍纯”等2件商标注册申请
证券之星 · 09-11
康恩贝新提交“Conba7Spro”、“康恩贝倍纯”等2件商标注册申请
股市必读:康恩贝(600572)9月4日董秘有最新回复
证券之星 · 09-07
股市必读:康恩贝(600572)9月4日董秘有最新回复
每周股票复盘:康恩贝(600572)完成东阳康恩贝股权工商变更
证券之星 · 09-06
每周股票复盘:康恩贝(600572)完成东阳康恩贝股权工商变更
康恩贝:截至8月10日,公司股东总户数为87,333户
证券之星 · 09-04
康恩贝:截至8月10日,公司股东总户数为87,333户
康恩贝(600572)披露公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告,8月31日股价下跌1.33%
证券之星 · 08-31
康恩贝(600572)披露公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告,8月31日股价下跌1.33%
每周股票复盘:康恩贝(600572)Q2扣非净利增61.12%
证券之星 · 08-30
每周股票复盘:康恩贝(600572)Q2扣非净利增61.12%
股市必读:康恩贝中报 - 第二季度单季净利润同比增长9.20%
证券之星 · 08-27
股市必读:康恩贝中报 - 第二季度单季净利润同比增长9.20%
康恩贝(600572)披露2026年半年度报告全文,8月25日股价上涨2.14%
证券之星 · 08-25
康恩贝(600572)披露2026年半年度报告全文,8月25日股价上涨2.14%
康恩贝上半年净利润同比增长6.83%
投资观察 · 08-25
康恩贝上半年净利润同比增长6.83%
每周股票复盘:森林包装(605500)5098.27万元竞得康恩贝印包100%股权
证券之星 · 08-23
每周股票复盘:森林包装(605500)5098.27万元竞得康恩贝印包100%股权
股市必读:森林包装新发布《森林包装集团股份有限公司关于购买东阳市康恩贝印刷包装有限公司100%股权的进展公告》
证券之星 · 08-19
股市必读:森林包装新发布《森林包装集团股份有限公司关于购买东阳市康恩贝印刷包装有限公司100%股权的进展公告》
公司概况
公司名称:
浙江康恩贝制药股份有限公司
所属行业:
医药制造业
上市日期:
2004-04-12
主营业务:
浙江康恩贝制药股份有限公司的主营业务是药品、中药材饮片及健康消费品的研发、制造与销售业务。公司的主要产品是“前列康”普乐安片及胶囊、“天保宁”银杏叶制剂、“康恩贝”肠炎宁、“金奥康”奥美拉唑产品、“金笛”复方鱼腥草合剂、“金艾康”汉防己甲素、“金康速力”乙酰半胱氨酸泡腾片、“至心砃”麝香通心滴丸、“康恩贝”“宝芝林”“养营堂”品牌系列保健食品和功能性食品。公司工业树种选育与产业关键技术项目获国家科学技术进步二等奖、数智中药大健康产业体系及应用项目获浙江省科学技术进步二等奖。
发行价格:
8.25
{"stockData":{"symbol":"600572","market":"SH","secType":"STK","nameCN":"康恩贝","latestPrice":4.26,"timestamp":1792047600000,"preClose":4.38,"halted":0,"volume":58352855,"delay":0,"changeRate":-0.0274,"floatShares":2534000000,"shares":2540000000,"eps":0.1963,"marketStatus":"已收盘","change":-0.12,"latestTime":"10-15 15:00:00","open":4.31,"high":4.36,"low":4.23,"amount":250000000,"amplitude":0.0297,"askPrice":4.27,"askSize":3545,"bidPrice":4.26,"bidSize":1728,"shortable":0,"etf":0,"ttmEps":0.1963,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792114200000},"marketStatusCode":5,"adr":0,"adjPreClose":4.38,"symbolType":"stock","openAndCloseTimeList":[[1792027800000,1792035000000],[1792040400000,1792047600000]],"highLimit":4.82,"lowLimit":3.94,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2540334471,"isCdr":false,"pbRate":1.53,"roa":"--","peRate":21.701477,"roe":"5.26%","epsLYR":0.19,"committee":0.204736,"marketValue":10822000000,"turnoverRate":0.023,"status":1,"floatMarketCap":10793000000},"requestUrl":"/m/hq/s/600572/wiki","defaultTab":"wiki","newsList":[{"id":"2675345031","title":"10月14日康恩贝发布公告,股东减持1000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675345031","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675345031?lang=zh_cn&edition=full","pubTime":"2026-10-14 19:01","pubTimestamp":1791975677,"startTime":"0","endTime":"0","summary":"证券之星消息,10月14日康恩贝发布公告《康恩贝:关于公司股东集中竞价减持股份计划的公告》,其股东胡季强于2026年3月7日至2026年10月14日间合计减持1000.0万股,占公司目前总股本的0.3936%,变动期间该股股价上涨0.46%,截止10月14日收盘报4.38元。股东增减持详情见下表:根据康恩贝2026年中报公布的十大股东详情如下:本文数据来源于康恩贝公告,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400033607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600572","BK0060","BK0188","BK0028","BK0012","BK0097","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675310095","title":"康恩贝(600572.SH):康恩贝集团拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675310095","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675310095?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:56","pubTimestamp":1791971788,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康恩贝(600572.SH)发布公告,公司第二大股东康恩贝集团因发展自身业务的资金需求,拟自公告披露之日后15个交易日后的3个月内通过上海证券交易所以集中竞价交易的方式减持公司股份,拟减持股份数量不超过2540.3万股,拟减持比例不超过公司总股本的1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0239","BK0028","BK0188","BK0060","600572","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674837075","title":"康恩贝:进入“十五五”阶段,公司在外延并购方面将聚焦做长长板","url":"https://stock-news.laohu8.com/highlight/detail?id=2674837075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674837075?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:21","pubTimestamp":1791537700,"startTime":"0","endTime":"0","summary":"证券之星消息,康恩贝10月09日在投资者关系平台上答复投资者关心的问题。投资者提问:公司当初承诺在十四五期间,收购1-2家医药公司或上市公司,十四五期间都过完了,公司的承诺一直没兑现,现在都是十五五期间,公司还有计划进行并购或收购计划?公司在“十四五”期间积极筛选、跟进多个潜在医药并购标的,受医药行业市场环境等多重因素影响,相关并购事项未能落地。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900026666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600572","BK0012","BK0028","BK0060","BK0239","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674837019","title":"康恩贝:公司当前暂无发行超短期融资券、中期票据安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2674837019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674837019?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:21","pubTimestamp":1791537699,"startTime":"0","endTime":"0","summary":"证券之星消息,康恩贝(600572)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问:关于公司发行中期票据和超短期融资券获准注册的公告,己披露很久了,公司计划什么时候开始融资?康恩贝回复:尊敬的投资者您好!公司申请注册发行额度各不超过10亿元人民币的超短期融资券、中期票据已于2025年9月完成中国银行间市场交易商协会注册。公司当前暂无发行超短期融资券、中期票据安排,后续将结合公司资金需求、融资规划及资本市场环境综合评估是否发行,若有相关进展将按监管要求及时履行信息披露义务。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900026664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600572","BK0097","BK0028","BK0060","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883707","title":"康恩贝:截至9月30日,公司股东总户数为90,869户","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883707","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674883707?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:21","pubTimestamp":1791537687,"startTime":"0","endTime":"0","summary":"证券之星消息,康恩贝(600572)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至9月30日公司股东人数是多少,谢谢康恩贝回复:尊敬的投资者您好!截至9月30日,公司股东总户数为90,869户。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900026658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","600572","BK0012","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003930","title":"康恩贝(600572)披露2026年第三季度股票期权激励计划自主行权结果暨股份变动公告,10月8日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673003930?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:18","pubTimestamp":1791469097,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘,康恩贝报收于4.3元,较前一交易日下跌0.23%,最新总市值为109.23亿元。公告显示,公司2022年股票期权激励计划在2026年第三季度内,首次授予股票期权第二个行权期有53名激励对象行权,行权股票数量为171.9740万股,全部为无限售条件流通股,已完成股份登记过户,新增股份已于行权日后第二个交易日上市交易。公司股本总数相应增加,股权分布仍具备上市条件,实际控制人未发生变化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800034401.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600572","BK0012","BK0239","BK0028","BK0188","BK0097","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673668075","title":"康恩贝(600572.SH)子公司盐酸达泊西汀片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2673668075","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673668075?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:07","pubTimestamp":1791454052,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康恩贝(600572.SH)发布公告,近日,公司全资子公司杭州康恩贝制药有限公司收到国家药品监督管理局核准签发的两个规格(规格:30mg、60mg)的盐酸达泊西汀片《药品注册证书》。盐酸达泊西汀片属于短效选择性5-羟色胺再摄取抑制剂,临床适用于18至64岁男性早泄(PE)患者的治疗,具有吸收快、起效迅速、半衰期短等特点,安全性、耐受性良好。该药品以化学药品4类获批,视同通过仿制药一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康恩贝(600572.SH)子公司盐酸达泊西汀片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","BK0060","BK0097","BK0012","BK0188","600572"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673014955","title":"股市必读:康恩贝新发布《公司第十一届董事会第二十一次(临时)会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673014955","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673014955?lang=zh_cn&edition=full","pubTime":"2026-10-08 00:58","pubTimestamp":1791392289,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘,康恩贝报收于4.31元,上涨1.65%,换手率1.82%,成交量46.1万手,成交额1.98亿元。公司公告汇总公司第十一届董事会第二十一次(临时)会议决议公告浙江康恩贝制药股份有限公司于2026年9月29日召开第十一届董事会第二十一次(临时)会议,审议通过关于公司董事、高级管理人员2025年度业绩考核结果及年薪清算结果的议案;同时审议通过2026年度及任期经营业绩考核方案,明确董事薪酬原则及高管薪酬考核机制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","600572","BK0060","BK0028","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671484266","title":"康恩贝(600572)9月28日主力资金净买入1260.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671484266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671484266?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:23","pubTimestamp":1790641431,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月28日收盘,康恩贝报收于4.25元,上涨0.95%,换手率1.29%,成交量32.65万手,成交额1.38亿元。近5日资金流向一览见下表:康恩贝融资融券信息显示,融资方面,当日融资买入725.27万元,融资偿还885.83万元,融资净偿还160.56万元。康恩贝主营业务:药品、中药饮片及大健康产品的研发、制造及销售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0012","600572","BK0028","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666118815","title":"康恩贝新提交“Conba7Spro”、“康恩贝倍纯”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666118815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666118815?lang=zh_cn&edition=full","pubTime":"2026-09-11 07:14","pubTimestamp":1789082063,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日浙江康恩贝制药股份有限公司新提交“Conba7Spro”、“康恩贝倍纯”等2件商标注册申请。商标申请详情如下:今年以来浙江康恩贝制药股份有限公司新申请注册商标10件,截止目前公司共持有注册商标864件,另有121件商标尚在注册申请中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100013341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","BK0188","600572","BK0097","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362206","title":"股市必读:康恩贝(600572)9月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362206?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:02","pubTimestamp":1788714142,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,康恩贝报收于4.39元,下跌0.45%,换手率1.54%,成交量39.07万手,成交额1.72亿元。董秘最新回复投资者: 尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月10日A股股东人数是多少?截至8月20日,公司股东总户数为99,786户,其中机构户数为5,766户。当日关注点交易信息汇总:9月4日主力资金净流入594.55万元,占总成交额3.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","600572","BK0060","BK0028","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365232","title":"每周股票复盘:康恩贝(600572)完成东阳康恩贝股权工商变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365232?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:28","pubTimestamp":1788632892,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,康恩贝报收于4.39元,较上周的4.5元下跌2.44%。本周,康恩贝9月1日盘中最高价报4.55元。双方于2026年8月17日签署股权交易合同,康恩贝已于8月19日收到全部股权转让款。2026年8月31日,东阳康恩贝完成工商变更登记备案,更名为东阳市森林包装有限公司,康恩贝不再持有其股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600572","BK0097","BK0028","BK0012","BK0188","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380493","title":"康恩贝:截至8月10日,公司股东总户数为87,333户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664380493?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:39","pubTimestamp":1788511162,"startTime":"0","endTime":"0","summary":"证券之星消息,康恩贝(600572)09月04日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月10日A股股东人数是多少?谢谢康恩贝回复:尊敬的投资者您好!截至8月10日,公司股东总户数为87,333户。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400029107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","600572","BK0060","BK0097","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079009","title":"康恩贝(600572)披露公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告,8月31日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079009","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663079009?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:20","pubTimestamp":1788186043,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,康恩贝报收于4.44元,较前一交易日下跌1.33%,最新总市值为112.71亿元。近日,浙江康恩贝制药股份有限公司发布《关于公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告》。公告显示,公司根据第十一届董事会第十七次(临时)会议决议,通过浙江产权交易所公开挂牌转让所持东阳市康恩贝印刷包装有限公司100%股权。双方于2026年8月17日签署股权交易合同,康恩贝已于8月19日收到全部股权转让款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0012","BK0188","BK0239","BK0060","600572","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663704323","title":"每周股票复盘:康恩贝(600572)Q2扣非净利增61.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663704323","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663704323?lang=zh_cn&edition=full","pubTime":"2026-08-30 08:19","pubTimestamp":1788049153,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,康恩贝报收于4.5元,较上周的4.32元上涨4.17%。本周,康恩贝8月26日盘中最高价报4.65元。本周关注点来自业绩披露要点:2026年第二季度扣非净利润2.16亿元,同比上升61.12%。股本股东变化截至2026年7月31日,公司股东户数为8.68万户,较7月20日减少2112户,减幅2.37%。第二季度单季主营收入17.96亿元,同比增7.3%;单季归母净利润1.79亿元,同比增9.2%;单季扣非净利润2.16亿元,同比增61.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0012","BK0239","BK0060","BK0188","BK0028","600572"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662032744","title":"股市必读:康恩贝中报 - 第二季度单季净利润同比增长9.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662032744","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662032744?lang=zh_cn&edition=full","pubTime":"2026-08-27 04:28","pubTimestamp":1787776091,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘,康恩贝报收于4.44元,上涨3.26%,换手率4.91%,成交量124.27万手,成交额5.59亿元。业绩披露要点:2026年中报显示扣非净利润4.25亿元,同比大增43.38%;第二季度扣非净利润同比增长61.12%。业绩披露要点财务报告2026年中报显示:主营收入37.01亿元,同比上升10.21%;归母净利润3.78亿元,同比上升6.83%;扣非净利润4.25亿元,同比上升43.38%;第二季度单季度扣非净利润2.16亿元,同比上升61.12%;负债率29.37%,毛利率56.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700009793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600572"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662614753","title":"康恩贝(600572)披露2026年半年度报告全文,8月25日股价上涨2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662614753","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662614753?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:36","pubTimestamp":1787668564,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,康恩贝报收于4.3元,较前一交易日上涨2.14%,最新总市值为109.16亿元。该股当日开盘4.19元,最高4.32元,最低4.18元,成交额达2.6亿元,换手率为2.4%。近日,浙江康恩贝制药股份有限公司披露《2026年半年度报告全文》。公司无半年度利润分配预案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500051276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0028","BK0239","600572","BK0188","BK0012","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193039397","title":"康恩贝上半年净利润同比增长6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193039397","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193039397?lang=zh_cn&edition=full","pubTime":"2026-08-25 21:29","pubTimestamp":1787664565,"startTime":"0","endTime":"0","summary":"8月25日消息——浙江康恩贝制药股份有限公司(证券代码:600572)披露了2026年半年度业绩报告,期内净利润较上年同期实现了6.83%的增长。\n这一数据反映出公司在上半年经营中的稳健表现。尽管市场环境复杂多变,康恩贝仍保持了业绩的持续增长势头。具体财务细节已在公司的官方报告中予以公布。\n据悉,该业绩数据来源于路透社投资者简报,信息更新于2026年8月25日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600572","BK0060","BK0239","BK0097","BK0028","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279214","title":"每周股票复盘:森林包装(605500)5098.27万元竞得康恩贝印包100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279214","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661279214?lang=zh_cn&edition=full","pubTime":"2026-08-23 04:56","pubTimestamp":1787432169,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,森林包装报收于6.95元,较上周的6.9元上涨0.72%。本周,森林包装8月18日盘中最高价报7.15元。8月21日盘中最低价报6.79元。本周关注点公司公告汇总:森林包装以5,098.27万元竞得东阳市康恩贝印刷包装有限公司100%股权。2026年8月17日,公司与浙江康恩贝制药股份有限公司签署《东阳市康恩贝印刷包装有限公司100%股权交易合同》。股权变更登记将在交易凭证出具后10个工作日内办理完毕,资产及资料移交在股权交易完成后10日内完成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300001244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","605500","BK0097","BK0188","BK0239","600572","BK0028","BK0222","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491321","title":"股市必读:森林包装新发布《森林包装集团股份有限公司关于购买东阳市康恩贝印刷包装有限公司100%股权的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491321","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491321?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:21","pubTimestamp":1787077272,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘,森林包装报收于7.12元,上涨1.57%,换手率0.95%,成交量3.93万手,成交额2777.34万元。当日关注点交易信息汇总:8月18日主力资金净流入399.92万元,占总成交额14.4%。公司公告汇总:森林包装于8月17日与浙江康恩贝制药签署股权交易合同,以5,098.27万元收购东阳市康恩贝印刷包装有限公司100%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","BK0097","BK0188","600572","BK0222","605500","BK0012"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792103624290,"stockEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0071},{"period":"3month","weight":-0.0047},{"period":"6month","weight":-0.0561},{"period":"1year","weight":-0.0072},{"period":"ytd","weight":-0.0093}],"compareEarnings":[{"period":"1week","weight":-0.0274},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0151},{"period":"6month","weight":-0.0849},{"period":"1year","weight":-0.0523},{"period":"ytd","weight":-0.0659}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江康恩贝制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"90869人(较上一季度减少0.58%)","perCapita":"27881股","listingDate":"2004-04-12","address":"浙江省金华市兰溪市康恩贝大道1号","registeredCapital":"254033万元","survey":" 浙江康恩贝制药股份有限公司的主营业务是药品、中药材饮片及健康消费品的研发、制造与销售业务。公司的主要产品是“前列康”普乐安片及胶囊、“天保宁”银杏叶制剂、“康恩贝”肠炎宁、“金奥康”奥美拉唑产品、“金笛”复方鱼腥草合剂、“金艾康”汉防己甲素、“金康速力”乙酰半胱氨酸泡腾片、“至心砃”麝香通心滴丸、“康恩贝”“宝芝林”“养营堂”品牌系列保健食品和功能性食品。公司工业树种选育与产业关键技术项目获国家科学技术进步二等奖、数智中药大健康产业体系及应用项目获浙江省科学技术进步二等奖。","listedPrice":8.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康恩贝(600572)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康恩贝(600572)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康恩贝,600572,康恩贝股票,康恩贝股票老虎,康恩贝股票老虎国际,康恩贝行情,康恩贝股票行情,康恩贝股价,康恩贝股市,康恩贝股票价格,康恩贝股票交易,康恩贝股票购买,康恩贝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康恩贝(600572)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康恩贝(600572)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}